Isomorphic Labs Enters into a Research Collaboration with Johnson & Johnson

Isomorphic Labs announced a new research collaboration with Johnson & Johnson, applying its AI-first Unified Drug Design Engine to accelerate discovery of small-molecule and biologic therapeutics. The deal adds to the company’s growing roster of pharmaceutical partnerships, which also includes Novartis and Eli Lilly.